Fox Run Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Fox Run Management's AVIR Position: Q3 2026 in Review
Fox Run Management opened a new position in Atea Pharmaceuticals (AVIR) in Q3 2026: 10,245 shares worth $53.4K. The stake represents 0.01% of the portfolio and ranks #921 among its holdings.
126 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Fox Run Management held 10,245 shares of Atea Pharmaceuticals worth $53.4K as of Q3 2026.
- Atea Pharmaceuticals was a new Fox Run Management position in Q3 2026.
- Atea Pharmaceuticals made up 0.01% of Fox Run Management's portfolio in Q3 2026, its #921 holding.
- 126 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.